Upadacitinib Effects on Entheseal Domain in Psoriatic Arthritis Patients - a Pooled "post-hoc" Analysis from Two Phase III Studies (Select PsA 1 and 2)

被引：0
|
作者：
Cantini, Fabrizio [1 ]
Marchesoni, Antonio [2 ]
Marando, Francesca [3 ]
Gualberti, Giuliana [3 ]
Novelli, Lucia [3 ]
Curradi, Giacomo [3 ]
McDearmon--Blondell, Erin [4 ]
Gao, Tianming [5 ]
Salvarani, Carlo [6 ]
机构：
[1] Hosp Prato, Dept Rheumatol, Azienda USL Toscana Ctr, Prato, Italy
[2] ASST Gaetano Pini CTO, Dipartimento Reumatol, Milan, Italy
[3] AbbVie, Rome, Italy
[4] AbbVie Inc, Elmhurst, IL USA
[5] AbbVie Inc, N Chicago, IL USA
[6] Azienda USL IRCCS Reggio Emilia, Unita Operat Reumatol, Reggio Emilia, Italy
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1340
引用
收藏
页码：2789 / 2791
页数：3
相关论文
共 50 条
  • [21] UPADACITINIB RESPONSE RATES IN PATIENTS WITH PSORIATIC ARTHRITIS ENROLLED IN THE SELECT-PSA-1 AND SELECT-PSA-2 TRIALS ASSESSED ACCORDING TO MODIFIED PSARC
    Coates, Laura C.
    Garrood, Toby
    Gullick, Nicola
    Helliwell, Philip
    Kent, Toby
    Marks, Jonathan
    Tillett, William
    Kaur-Papadakis, Daljit
    Tahir, Hasan
    van Haaren, Stijn
    McInnes, Iain
    RHEUMATOLOGY, 2021, 60
  • [22] Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC
    Coates, Laura C.
    Garrood, Toby
    Gullick, Nicola
    Helliwell, Philip
    Kent, Toby
    Marks, Jonathan
    Tillett, William
    Kaur-Papadakis, Daljit
    Tahir, Hasan
    van Haaren, Stijn
    McInnes, Iain
    RHEUMATOLOGY, 2022, 62 (01) : E1 - E3
  • [23] Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme
    Fleischmann, Roy
    Curtis, Jeffrey R.
    Charles-Schoeman, Christina
    Mysler, Eduardo
    Yamaoka, Kunihiro
    Richez, Christophe
    Palac, Hannah
    Dilley, Deanne
    Liu, Jianzhong
    Strengholt, Sander
    Burmester, Gerd
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (09) : 1130 - 1141
  • [24] Effects of once-Daily Opicapone 50 mg on COMT activity: A Pooled Post-hoc Analysis of Two Phase 1 Studies
    Loewen, G.
    Vijan, A.
    Olson, K.
    O'Reilly, T.
    Liang, G.
    Klepitskaya, O.
    MOVEMENT DISORDERS, 2022, 37 : S457 - S457
  • [25] LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 1 STUDY
    Mcinnes, I.
    Kato, K.
    Magrey, M.
    Merola, J. F.
    Kishimoto, M.
    Haaland, D.
    Chen, L.
    Duan, Y.
    Liu, J.
    Lippe, R.
    Wung, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 260 - 261
  • [26] Secukinumab demonstrates high and sustained efficacy in nail psoriasis: Post hoc analyses from phase III studies in psoriasis and psoriatic arthritis (PsA)
    Reich, Kristian
    Baraliakos, Xenofon
    Coates, Laura C.
    Gottlieb, Alice B.
    Elewski, Boni
    Bao, Weibin
    Kasparek, Torben
    Gaillez, Corine
    Pournara, Effie
    Aassi, Maher
    Perella, Chiara
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB56 - AB56
  • [27] TREATING RHEUMATOID ARTHRITIS PATIENTS WITH MODERATE DISEASE ACTIVITY: AN ANALYSIS OF THE UPADACITINIB SELECT PHASE III RANDOMISED STUDIES
    Conaghan, Phillip G.
    Pavelka, Karel
    Hsieh, Song-Chou
    Bonnington, Terri-Leigh
    Kent, Toby C.
    Edwards, Christopher J.
    RHEUMATOLOGY, 2021, 60
  • [28] Efficacy of Tofacitinib By Background Methotrexate Dose in Patients with Psoriatic Arthritis: A Post Hoc Analysis of Pooled Data from 2 Phase 3 Trials
    Kivitz, Alan J.
    FitzGerald, Oliver
    Nash, Peter
    Pang, Shirley
    Azevedo, Valderilio F.
    Kudlacz, Elizabeth
    Wang, Cunshan
    Graham, Daniela
    Takiya, Liza
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [29] Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies
    Mease, Philip J.
    Helliwell, Philip S.
    Gladman, Dafna D.
    Poddubnyy, Denis
    Baraliakos, Xenofon
    Chakravarty, Soumya D.
    Kollmeier, Alexa P.
    Hsia, Elizabeth C.
    Xu, Xie L.
    Sheng, Shihong
    Agarwal, Prasheen
    Zhou, Bei
    Sweet, Kristen
    Shawi, May
    Karyekar, Chetan S.
    Deodhar, Atul
    van der Heijde, Desiree
    LANCET RHEUMATOLOGY, 2021, 3 (10): : E715 - E723
  • [30] Tofacitinib in Patients With Psoriatic Arthritis and Metabolic Syndrome: A Post hoc Analysis of Phase 3 Studies
    Ritchlin, Christopher T.
    Giles, Jon T.
    Ogdie, Alexis
    Gomez-Reino, Juan J.
    Helliwell, Philip
    Young, Pamela
    Wang, Cunshan
    Wu, Joseph
    Romero, Ana Belen
    Woolcott, John
    Stockert, Lori
    ACR OPEN RHEUMATOLOGY, 2020, 2 (10) : 543 - 554
12345